Abstract
Genome-wide screening is anticipated to accelerate the development of personalized medicine by identifying and exploiting new associations between genomic variants and drug responses. However, this goal could be undermined if care is not taken to minimize the impact of pharmacogenomic associations that turn out to have narrower implications than suggested by initial studies.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Head-and-neck squamous cell carcinoma risk in smokers: no association detected between phenotype and AHR, CYP1A1, CYP1A2, or CYP1B1 genotype
Human Genomics Open Access 28 November 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Committee on a Framework for Development of a New Taxonomy of Disease; National Research Council. Toward precision medicine: building a knowlege network for biomedical research and a new taxonomy of disease. (National Academies Press, Washington DC, 2011).
Kohane, I. S., Masys, D. R. & Altman, R. B. The incidentalome: a threat to genomic medicine. JAMA 296, 212–215 (2006).
Beutler, E. et al. Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 359, 211–218 (2002).
Thauvin-Robinet, C. et al. The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counselling and newborn screening. J.Med. Genet. 46, 752–758 (2009).
Murray, M. L. et al. Follow-up of carriers of BRCA1 and BRCA2 variants of unknown significance: variant reclassification and surgical decisions. Genetics Med. 13, 998–1005 (2011).
Kohane, I. S. Using electronic health records to drive discovery in disease genomics. Nature Rev. Genet. 12, 417–428 (2011).
Johansson, I. & Ingelman-Sundberg, M. CNVs of human genes and their implication in pharmacogenetics. Cytogenetic Genome Res. 123, 195–204 (2008).
Kohane, I. S. et al. Medicine. Reestablishing the researcher-patient compact. Science 316, 836–837 (2007).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Kohane, I. (Mis)treating the pharmacogenetic incidentalome. Nat Rev Drug Discov 11, 89–90 (2012). https://doi.org/10.1038/nrd3659
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd3659